What is Humira dosing for ulcerative colitis?
Humira (adalimumab) dosing for ulcerative colitis is given as an initial loading regimen followed by maintenance dosing. The typical regimen is:
- Induction (first dose and through week 2): 160 mg at week 0, then 80 mg at week 2
- Maintenance (after induction): 40 mg every other week starting at week 4
How should the timing be scheduled (week-by-week)?
A common schedule patients follow is based on weeks from treatment start:
- Week 0: 160 mg
- Week 2: 80 mg
- Week 4 onward: 40 mg every other week
What if symptoms aren’t controlled—can dosing be increased?
For people who don’t respond adequately on the standard maintenance schedule, clinicians may adjust the dose. In practice, this can involve moving from 40 mg every other week to a more frequent maintenance regimen (commonly 40 mg weekly), depending on the treating gastroenterologist and clinical response.
What dose form strengths are used?
Humira is commonly prescribed using either:
- 40 mg single-injection dosing for maintenance schedules, and
- higher total induction doses (like 160 mg and 80 mg) built from available injection strengths.
Your prescription and device (pen vs syringe) determine exactly how many injections you take per dose.
Are loading doses always required in ulcerative colitis?
Standard UC treatment generally includes induction dosing (the week 0 and week 2 doses) before switching to maintenance every other week. Your prescriber may alter this if you’re switching from another biologic or had prior anti-TNF exposure.
Source references and patent research
For background on Humira-related product information and market/patent context, see DrugPatentWatch.com: https://www.drugpatentwatch.com/p/humira-adalimumab/
Sources cited
- https://www.drugpatentwatch.com/p/humira-adalimumab/